Gregory Robertson, MD
Interventional Cardiology · Johns Creek, GANPI 1598776809
Payments from drug & device makers
Across 86 payments — averaging $91.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Cordis US CORP.$2K
- Inari Medical, Inc.$1K
- Boston Scientific$691
- Penumbra, Inc.$605
- Avinger Inc.$452
- plus $760 from 14 others
What the payments were for
- Speaking & faculty fees$1,68821%
- Travel & lodging$3,06839%
- Food & beverage$3,09639%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $2,483 |
| Cordis US CORP. | 8 | $1,675 |
| Inari Medical, Inc. | 4 | $1,187 |
| Boston Scientific | 18 | $691 |
| Penumbra, Inc. | 5 | $605 |
| Avinger Inc. | 8 | $452 |
| Endologix LLC | 2 | $209 |
| Abbott | 1 | $112 |
| Endovascular Engineering Inc. | 2 | $79 |
| Livanova USA, Inc. | 1 | $62 |
| Philips North America LLC | 3 | $52 |
| Stryker | 1 | $50 |
| W. L. Gore & Associates, Inc. | 1 | $42 |
| Shockwave Medical, Inc | 1 | $39 |
| Lilly USA, LLC | 1 | $26 |
| Teleflex LLC | 1 | $25 |
| Braemar Manufacturing, LLC | 1 | $22 |
| Surmodics, Inc. | 3 | $16 |
| Asahi Intecc USA, Inc. | 1 | $15 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolute$1,956
- FLOWTRIEVER CATHETER, S$1,115
- CT THROMBECTOMY SYSTEM KIT$1,115
- Mynx Venous VCD$827
- ANGIOGUARD$677
- Indigo System$596
- ROTAPRO$263
- PANTHERIS$202
- Alto Abdominal Stent Graft System$175
- Amplatzer Cardiac Plug$112
How this compares
$7,852 in reported general payments places this provider in the 45th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 221 | $273,852 |
| XareltoRivaroxaban | 49 | $64,504 |
| BrilintaTicagrelor | 22 | $24,958 |
| FarxigaDapagliflozin Propanediol | 16 | $23,160 |
| Praluent PenAlirocumab | 20 | $10,591 |
| Prasugrel Hcl | 15 | $3,483 |
| Atorvastatin Calcium | 270 | $2,164 |
| Rosuvastatin Calcium | 213 | $2,149 |
| Ezetimibe | 48 | $1,791 |
| Metoprolol Succinate | 128 | $1,572 |
| ClopidogrelClopidogrel Bisulfate | 147 | $1,372 |
| Carvedilol | 211 | $1,280 |
| Lisinopril | 140 | $895 |
| Losartan Potassium | 94 | $886 |
| Amlodipine Besylate | 180 | $846 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Johns Creek
- David KandzariAtlanta$3.7M
- Pradeep YadavAtlanta$3.5M
- Vasilis BabaliarosAtlanta$2.7M
- Megan CoylewrightCalhoun$2.3M
- William NicholsonAtlanta$2M
- Chandanreddy DevireddyAtlanta$1.9M
- Adam GreenbaumAtlanta$1.8M
- Amar PatelMarietta$1.8M
- Vivek RajagopalAtlanta$1.3M
- Christopher MeduriAtlanta$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.